How Sleep Loss Amplifies Pain
November 20, 2023
Chronic pain, a pervasive condition affecting 11–40% of adults, is ...
Read More
New Guidelines for Cannabis in Chronic Pain Management Released
April 20, 2023
In this timely study, researchers performed a systematic review of ...
Read More
FDA Approves Ubrogepant for Acute Treatment of Migraine
January 24, 2020
Schizophrenia is a lifelong illness affecting approximately 2.4 mil...
Read More
FDA Does Not Approve Sublingual Buprenorphine Spray for Pain
August 13, 2018
The FDA has opted not to approve a new formulation of the opioid me...
Read More
Can Cannabis Use Reduce Opioid Use?
February 9, 2018
Given the ongoing prescription opioid use disorder epidemic as well...
Read More
Increased Risk of Opioid-Related Death in Patients Taking Concomitant Gabapentin
October 16, 2017
A new study examined the increased risk for opioid-related death in...
Read More
Highlights from the 2017 APA Annual Meeting
June 8, 2017
The 2017 APA annual meeting, held in NEI's hometown of San Diego, w...
Read More
Report on Health Effects of Cannabis Released by National Academies of Sciences, Engineering, and Medicine
February 3, 2017
With the recent legalization of both medical and recreational use i...
Read More
Increase in Opioid-Related Deaths Not Driven By Prescription Painkillers
January 12, 2017
Opioid abuse remains an epidemic in the United States, with over 50...
Read More
Oral Ketamine Relieves Depression in Patients with Chronic Pain
November 17, 2016
In a six-week randomized, double-blind study, 150 mg of oral ketami...
Read More
FDA Alert: Medication and Medical Device Approvals
September 12, 2016
The US FDA has approved the marketing of computerized cognitive tes...
Read More
FDA Alert: Boxed Warning for Combined Use of Opioids and Benzodiazepines
September 2, 2016
The US FDA is added a boxed warning to the labels of opioid pain an...
Read More